Can Core MedSurg Segment Drive Stryker's (SYK) Q1 Earnings?
Zacks Investment Research | Apr 16, 2019 11:13PM ET
Stryker Corporation’s (NYSE:SYK) first-quarter 2019 results are scheduled for release on Apr 23 after market close. Results are likely to be driven by a strong show of the core MedSurg segment. A bullish 2019 view also buoys optimism on the stock.
Which Way Are Estimates Trending?
The Zacks Consensus Estimate for first-quarter earnings per share is pegged at $1.84, reflecting a year-over-year improvement of 9.5%.
The same for revenues stands at $3.52 billion, mirroring 8.5% growth over the prior-year quarter.
Let’s see how things are shaping up before the earnings release.
MedSurg in Focus
This segment consists of surgical instruments plus endoscopic and emergency medical equipment. Significantly, it has been consistently driving Stryker’s top line.
It is encouraging to note that for the quarter to be reported, the Zacks Consensus Estimate for the segment’s revenues stands at $1.52 billion, up 6.7% year over year.
Stryker Corporation Price and EPS Surprise
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.